Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-12-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-06339-1 |
_version_ | 1797388101586255872 |
---|---|
author | Santiago Madera Franco Izzo María F. Chervo Agustina Dupont Violeta A. Chiauzzi Sofia Bruni Ezequiel Petrillo Sharon S. Merin Mara De Martino Diego Montero Claudio Levit Gabriel Lebersztein Fabiana Anfuso Agustina Roldán Deamicis María F. Mercogliano Cecilia J. Proietti Roxana Schillaci Patricia V. Elizalde Rosalía I. Cordo Russo |
author_facet | Santiago Madera Franco Izzo María F. Chervo Agustina Dupont Violeta A. Chiauzzi Sofia Bruni Ezequiel Petrillo Sharon S. Merin Mara De Martino Diego Montero Claudio Levit Gabriel Lebersztein Fabiana Anfuso Agustina Roldán Deamicis María F. Mercogliano Cecilia J. Proietti Roxana Schillaci Patricia V. Elizalde Rosalía I. Cordo Russo |
author_sort | Santiago Madera |
collection | DOAJ |
first_indexed | 2024-03-08T22:34:52Z |
format | Article |
id | doaj.art-f97153e8a240450a80194174d2482fd7 |
institution | Directory Open Access Journal |
issn | 2041-4889 |
language | English |
last_indexed | 2024-03-08T22:34:52Z |
publishDate | 2023-12-01 |
publisher | Nature Publishing Group |
record_format | Article |
series | Cell Death and Disease |
spelling | doaj.art-f97153e8a240450a80194174d2482fd72023-12-17T12:31:44ZengNature Publishing GroupCell Death and Disease2041-48892023-12-0114121310.1038/s41419-023-06339-1Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancerSantiago Madera0Franco Izzo1María F. Chervo2Agustina Dupont3Violeta A. Chiauzzi4Sofia Bruni5Ezequiel Petrillo6Sharon S. Merin7Mara De Martino8Diego Montero9Claudio Levit10Gabriel Lebersztein11Fabiana Anfuso12Agustina Roldán Deamicis13María F. Mercogliano14Cecilia J. Proietti15Roxana Schillaci16Patricia V. Elizalde17Rosalía I. Cordo Russo18Laboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETNew York Genome CenterLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETUniversidad de Buenos Aires (UBA), Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular and CONICET-UBA, Instituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE)Laboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETDepartment of Radiation Oncology, Weill Cornell MedicineLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETServicio de Ginecología, Sanatorio Sagrado CorazónServicio de Ginecología, Sanatorio Sagrado CorazónServicio de Ginecología, Sanatorio Sagrado CorazónLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICETLaboratory of Molecular Mechanisms of Carcinogenesis and Molecular Endocrinology, Instituto de Biología y Medicina Experimental (IBYME), CONICEThttps://doi.org/10.1038/s41419-023-06339-1 |
spellingShingle | Santiago Madera Franco Izzo María F. Chervo Agustina Dupont Violeta A. Chiauzzi Sofia Bruni Ezequiel Petrillo Sharon S. Merin Mara De Martino Diego Montero Claudio Levit Gabriel Lebersztein Fabiana Anfuso Agustina Roldán Deamicis María F. Mercogliano Cecilia J. Proietti Roxana Schillaci Patricia V. Elizalde Rosalía I. Cordo Russo Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer Cell Death and Disease |
title | Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer |
title_full | Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer |
title_fullStr | Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer |
title_full_unstemmed | Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer |
title_short | Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer |
title_sort | correction halting erbb 2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple negative breast cancer |
url | https://doi.org/10.1038/s41419-023-06339-1 |
work_keys_str_mv | AT santiagomadera correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT francoizzo correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT mariafchervo correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT agustinadupont correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT violetaachiauzzi correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT sofiabruni correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT ezequielpetrillo correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT sharonsmerin correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT marademartino correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT diegomontero correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT claudiolevit correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT gabriellebersztein correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT fabianaanfuso correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT agustinaroldandeamicis correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT mariafmercogliano correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT ceciliajproietti correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT roxanaschillaci correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT patriciavelizalde correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer AT rosaliaicordorusso correctionhaltingerbb2isoformsretrogradetransporttothenucleusasanewtheragnosticapproachfortriplenegativebreastcancer |